These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15049968

  • 1. Gender variation in PTH sensitivity and rhythmicity following growth hormone replacement in adult growth hormone-deficient patients.
    White HD, Ahmad AM, Syed AA, Clewes A, Peter R, Vora JP, Fraser WD.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):516-26. PubMed ID: 15049968
    [Abstract] [Full Text] [Related]

  • 2. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP.
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [Abstract] [Full Text] [Related]

  • 3. PTH circadian rhythm and PTH target-organ sensitivity is altered in patients with adult growth hormone deficiency with low BMD.
    White HD, Ahmad AM, Durham BH, Peter R, Prabhakar VK, Corlett P, Vora JP, Fraser WD.
    J Bone Miner Res; 2007 Nov; 22(11):1798-807. PubMed ID: 17645402
    [Abstract] [Full Text] [Related]

  • 4. Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism.
    Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2860-8. PubMed ID: 12788900
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormone-deficient patients.
    White HD, Ahmad AM, Durham BH, Patwala A, Whittingham P, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3371-80. PubMed ID: 15741264
    [Abstract] [Full Text] [Related]

  • 6. Effect of oral phosphate and alendronate on bone mineral density when given as adjunctive therapy to growth hormone replacement in adult growth hormone deficiency.
    White HD, Ahmad AM, Durham BH, Joshi AA, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):726-36. PubMed ID: 21252245
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF, Jensen JE, Eskildsen PC.
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency.
    Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH, Vora JP.
    Bone; 2003 Feb; 32(2):170-9. PubMed ID: 12633789
    [Abstract] [Full Text] [Related]

  • 9. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS, Cameron ID, Cumming RG, Lord SR, March LM, Sambrook PN, Simpson JM, Seibel MJ.
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [Abstract] [Full Text] [Related]

  • 10. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 11. Effect of active acromegaly and its treatment on parathyroid circadian rhythmicity and parathyroid target-organ sensitivity.
    White HD, Ahmad AM, Durham BH, Chandran S, Patwala A, Fraser WD, Vora JP.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):913-9. PubMed ID: 16352693
    [Abstract] [Full Text] [Related]

  • 12. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
    de Boer H, Blok GJ, Popp-Snijders C, Sips A, Lips P, van der Veen E.
    J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid responsiveness to hypocalcemic and hypercalcemic stimuli in adult growth hormone deficiency after growth hormone replacement.
    Ahmad AM, Hopkins MT, Thomas J, Durham BH, Fraser WD, Vora JP.
    Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E986-93. PubMed ID: 15140756
    [Abstract] [Full Text] [Related]

  • 14. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.
    Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265
    [Abstract] [Full Text] [Related]

  • 15. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis.
    Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF.
    J Bone Miner Res; 1994 Sep 22; 9(9):1365-70. PubMed ID: 7817819
    [Abstract] [Full Text] [Related]

  • 16. Consistency of bone turnover marker and calcium responses to parathyroid hormone (1-84) therapy in postmenopausal osteoporosis.
    Schafer AL, Palermo L, Bauer DC, Bilezikian JP, Sellmeyer DE, Black DM.
    J Clin Densitom; 2011 Sep 22; 14(1):68-73. PubMed ID: 21095149
    [Abstract] [Full Text] [Related]

  • 17. Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
    Zikan V, Stepan JJ.
    Bone; 2009 Apr 22; 44(4):634-8. PubMed ID: 19150421
    [Abstract] [Full Text] [Related]

  • 18. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, Lüftner D.
    Anticancer Res; 2007 Apr 22; 27(4A):1853-62. PubMed ID: 17649784
    [Abstract] [Full Text] [Related]

  • 19. [The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].
    Mohamed Y, Haifa H, Datel O, Fadoua HN, Smeh BH, Mahbouba J, Saoussen Z, Bejia I, Mongi T, Mohamed FN, Naceur B.
    Tunis Med; 2014 May 22; 92(5):304-10. PubMed ID: 25504382
    [Abstract] [Full Text] [Related]

  • 20. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
    Wilhelm B, Kann PH.
    Med Klin (Munich); 2004 Oct 15; 99(10):569-77. PubMed ID: 15490072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.